RecruitingNot ApplicableNCT06286917

Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency


Sponsor

Tampere University

Enrollment

120 participants

Start Date

Mar 5, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This research will study whether noninvasive ventilation (NIV) used to treat chronic respiratory insufficiency in patients with amyotrophic lateral sclerosis (ALS) can be initiated as successfully in the outpatient setting as in the conventional inpatient setting, and what the costs of these alternative initiation methods are.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying NIV initiation in patients with ALS for people with als, chronic respiratory failure, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNIV initiation in patients with ALS

NIV initiation according to standard care


Locations(1)

Tampere University Hospital

Tampere, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06286917


Related Trials